Stay updated on Nivolumab and Urelumab in Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Urelumab in Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Urelumab in Bladder Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The study has been updated to version v2.10.0, with 5 locations now included, replacing the previous version v2.9.7.
    Difference
    0.4%
    Check dated 2024-07-23T14:46:24.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T08:17:44.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-07-02T14:16:52.000Z thumbnail image
  8. Check
    30 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-27T10:21:27.000Z thumbnail image
  9. Check
    31 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-26T09:25:38.000Z thumbnail image
  10. Check
    32 days ago
    Change Detected
    Summary
    The value on the web page has changed from 'Show more Show more Revision: v2.9.0' to 'Show less MedlinePlus Genetics related topics: Bladder cancer MedlinePlus related topics: Bladder Cancer Genetic and Rare Diseases Information Center resources: Transitional Cell Carcinoma Drug Information available for: Nivolumab FDA Drug and Device Resources Show less'. This change indicates an update in the displayed information related to genetics, diseases, and drug resources.
    Difference
    24%
    Check dated 2024-06-25T08:37:20.000Z thumbnail image

Stay in the know with updates to Nivolumab and Urelumab in Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Urelumab in Bladder Cancer Clinical Trial page.